Work

Enhancing Immunotherapy for Cancer by Targeting Suppressive Myeloid cells

Year: 2020
Type: article
Abstract: Significant progress has been made in the development of immune-based therapies, yet despite promising results, a large portion of patients with advanced solid tumors do not respond to immune-based therapies or develop resistance after experiencing tumor shrinkage.The precise mechanisms underlying resistance are not well understood, although it is likely that inhibitory pathways are operational.To enhance immune-based therapies, we focused on studying two suppressive myeloid cell types termed myeloid-derived suppressor cells (MDSC) and tumor-associated macrophages (TAM) given their ability to contribute to immune therapy vii Dedication This work is dedicated to my father Dean, mother Lisa, and sister Breanne.Your unyielding love, support, and encouragement have inspired me to follow my passion to pursue and complete this research.I am fortunate to have been raised by a family who believes in me and who supports me, and who always makes me feel like my dreams are worth dreaming about and then fighting for.To my husband and best friend, Bryan, your love, patience, and acceptance have given me the determination to finish this journey.Thank you for believing in me, for knowing when to go to the "man cave" or outside to do yard
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W7028545543
FWCI: 0.079
Cites: 91
Cited by: 1
Related to: 10